About Moxidectin
Moxidectin is an ingredient of the milbemycin group among the macrocyclic lactones. The pharmacokinetics entry of the Merck Veterinary Manual states that the milbemycin group includes nemadectin, moxidectin and milbemycin 5-oxime, and explains that moxidectin is more soluble than ivermectin or doramectin. The same entry explains that this class shows broad activity against nematodes and arthropods at very small amounts.
Its forms are listed most variously in the preventive list of the American Heartworm Society. For dogs there are oral products, injectables and topical products, and for cats and ferrets there are topical products. The Society shows that among these the injectable is listed for dogs only. Some products are listed as combination products that contain other external parasite ingredients.
The cautions for the moxidectin injectable are in the label of the product approved by the US FDA (DailyMed posted copy). The label states heartworm prevention in dogs 6 months of age and older as the indication, that a test for existing heartworm infection must be done before administration, and that infected dogs must receive treatment to remove adult worms. It also states that anaphylaxis and similar reactions can occur in some dogs and have led to death in some cases, and says not to give it to dogs that are sick, debilitated, underweight, or have a history of weight loss. The label states that this product is supplied through restricted distribution, only to veterinarians who have completed Risk Minimization Action Plan (RiskMAP) training. However, apart from this label, the FDA notice documents could not be read and confirmed for this term.
The safety of anthelmintics entry of the Merck Veterinary Manual states that macrocyclic lactones depend on blood-brain barrier P-glycoprotein activity, and warns against using products made for other animal species in dogs off-label. Using livestock moxidectin products instead is not covered. This term does not set a dose or an interval, and actual administration follows a veterinarian's examination and the product instructions. This entry is an editorial draft and has not been professionally reviewed.
How it appears on labels
| On Korean labels | 동물용의약품 포장·설명서의 주성분(유효성분)란에 목시덱틴으로 적힌다. 다른 구충 성분과 함께 든 복합제가 있다. (Written as moxidectin in the main ingredient (active ingredient) field of the veterinary drug package and leaflet. Some combination products contain other antiparasitic ingredients.) |
|---|---|
| On English labels | Written as moxidectin on overseas labels. |
| Unit / basis | Not applicable |
Which standard is it?
- US FDA-approved label (moxidectin injectable, DailyMed posted copy): states the infection test before administration, the possibility of anaphylaxis, no administration to dogs that are debilitated or have lost weight, and restricted distribution.
- Merck Veterinary Manual (pharmacokinetics): states that moxidectin belongs to the milbemycin group and is more soluble than ivermectin.
- American Heartworm Society preventive list: moxidectin is listed as oral products, injectables and topical products for dogs, and topical products for cats and ferrets.
Common misconceptions
- Once the moxidectin injectable is given there is nothing more to attend to → The approved label states the infection test before administration, the possibility of anaphylaxis, and no administration to dogs in poor condition. If anything unusual appears after the injection, tell the animal hospital.
- Moxidectin is the same in every breed → The Merck Veterinary Manual states that the safety of macrocyclic lactones as a whole depends on P-glycoprotein activity. Discuss individual animals with a veterinarian.
What to check on the label
- Check in the product leaflet whether moxidectin is a single ingredient or a combination product, and whether it is an oral, topical or injectable form.
- Check the target animal (dog, cat), the age and weight conditions, and the heartworm test requirement in the approval details.
- Tell a veterinarian before administration about an animal that is sick or losing weight, or that has had a reaction to a drug in the past.
Related guides
Where was this checked?
- InternationalDailyMed (U.S. National Library of Medicine) · FDA-approved product label · Moxidectin 6-month extended-release injectable (moxidectin) label (목시덱틴 6개월 지속 주사제(moxidectin) 표시) ↗
The indication in dogs, the infection test before administration, the anaphylaxis warning, the conditions for no administration, and restricted distribution. (checked 2026-11-22)
- InternationalMerck Veterinary Manual · Pharmacokinetics of Anthelmintics in Animals ↗
The makeup of the milbemycin group and the description of moxidectin's solubility. (checked 2026-11-22)
- InternationalAmerican Heartworm Society · Heartworm Preventives ↗
The forms of moxidectin products (oral, injectable, topical) and the target animals. (checked 2026-11-22)
- InternationalMerck Veterinary Manual · Safety of Anthelmintics in Animals ↗
P-glycoprotein-dependent safety and the warning against off-label use of products made for other species. (checked 2026-11-22)
Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean entry is an explainer newly written from these sources, not a full translation of them. Not a diagnosis, prescription or feeding instruction. Korean edition checked 2026-11-22 · no paid partnerships.